PixL

About BIOPIX-T

Founded in 2019 as a spin-off from IMBB-FORTH, BIOPIX-T is building a diagnostics ecosystem centered on its proprietary, 3D-printed Pebble device, which performs real-time quantitative colorimetric LAMP (qcLAMP) assays. The company has achieved CE-IVD certification for its platform and associated test kits, targeting the infectious disease diagnostics market with a focus on accessibility and ease of use. Backed by venture capital and angel investors, BIOPIX-T is led by a team of scientists and professionals aiming to expand its product portfolio and global presence.

Therapeutic Areas